Multicenter Phase II Study of Panitumumab in Platinum Pretreated, Advanced Head and Neck Squamous Cell Cancer

LESSONS LEARNED. Panitumumab shows activity in terms of disease control rate and preventing disease progression but not for tumor shrinkage in head and neck squamous cell cancer for second‐line treatment. Epidermal growth factor receptor (EGFR) copy number gain, a property of tumor cells that theore...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Siano, Marco, Molinari, Francesca, Martin, Vittoria, Mach, Nicolas, Früh, Martin, Freguia, Stefania, Corradino, Irene, Ghielmini, Michele, Frattini, Milo, Espeli, Vittoria
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Clinical Trial Results
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5507653/
https://ncbi.nlm.nih.gov/pubmed/28592616
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0069
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados